EN
FR
Exporter
exporter
Exporter
PDF
Excel (XLSX)
Word (DOCX)
You can select particular sections to be included in the output file.
Select all
Select classic EML layout
Indication
ICD-11
Codes ATC
Type de liste
Formulations
Équivalence thérapeutique
Footnote
INN
Type de médicament
Groupes d'antibiotiques
Sexe
Âge
Limite d'âge
Restriction de poids
Renseignements sur le brevet
Expert Committee decision justification
Cancel
Exporter
EN
FR
Liste modèle des médicaments essentiels
Trouvé 13 recommandations pour 1 médicament et 1 équivalent thérapeutique
Les recommandations supprimées et les demandes rejetées sont affichées.
Les cacher
.
Pembrolizumab
Informations générales
Section
Immunomodulators
Parenteral > General injections > IV: 25 mg per mL in 4 mL vial
Parenteral > General injections > IV: 25 mg per mL in 4 mL vial concentrate for solution for infusion
Parenteral > General injections > IV: 25 mg per mL in 4 mL vial powder for injection
Indications
Melanoma of skin
Other specified malignant neoplasms of large intestine
Malignant neoplasms of cervix uteri
Adenocarcinoma of stomach
Malignant neoplasms of oesophagogastric junction
Squamous cell carcinoma of hypopharynx and variants
Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx
Squamous cell carcinoma of oropharynx
Squamous cell carcinoma of nasopharynx
Therapeutic equivalent to
nivolumab
pour
Melanoma of skin
Renal cell carcinoma of kidney, except renal pelvis
Carcinoma of breast, specialised type
Squamous cell carcinoma of oesophagus
Other specified malignant neoplasms of bronchus or lung